GREY:ATBPF - Post by User
Comment by
Montana5on Jan 21, 2024 7:53pm
247 Views
Post# 35838286
RE:RE:RE:also 🚩
RE:RE:RE:also 🚩A successful P2 for acute will likely move the share price to at least $2.50 for ATE to consider another equity issue. It would help self fund P3 and other potential developments (clinically and corporate).